Aikido Pharma Inc AIKI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
1.06UNCH (UNCH)
Volume
230,181
Close
1.06quote price arrow up+0.05 (+4.95%)
Volume
10,981,508
52 week range
0.47 - 5.46

...

Loading . . .

KEY STATS

  • Open1.05
  • Day High1.09
  • Day Low0.86
  • Prev Close1.01
  • 52 Week High5.46
  • 52 Week High Date03/09/20
  • 52 Week Low0.47
  • 52 Week Low Date11/02/20
  • Market Cap86.71M
  • Shares Out81.80M
  • 10 Day Average Volume20.58M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • 1 Year % Change-35.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.76
  • P/E (TTM)-1.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-8.341M
  • ROE (MRQ)-61.87%
  • Revenue (MRQ)10,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-129,888.90%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Aikido Pharma Inc News

There is no recent news for this security.

Latest AIKI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, the Company is constantly seeking to grow its pipeline to treat its unmet medical needs in oncology.
Robert Vander Zanden Ph.D.
Chairman
Anthony Hayes
Chief Executive Officer
Address
ONE ROCKEFELLER PLAZA, 11TH FLOOR
New York, NY
10020
United States